Coordination of Care for Patients with Duchenne Muscular Dystrophy: Teamwork is Everything Duchenne Muscular Dystrophy: Speaking with Patients and Families About Advanced Care ...
Bone health is important to those affected by Duchenne as many patients experience long bone and/or vertebral fractures before the age of 13. In the preclinical study sponsored by Catabasis, ...
The EMA has backed broader pediatric use of Agamree and Crysvita, lowering age thresholds for rare genetic diseases affecting muscle and bone development.
HACKENSACK, N.J., June 16, 2021 /PRNewswire/ — Parent Project Muscular Dystrophy (PPMD), a US nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), and Jesse’s ...
KROS sharpens focus on rinvatercept as a phase II DMD study looms in 2026, shifting the story toward execution and high-stakes clinical catalysts.
More than 30 rare muscular dystrophy types cause progressive muscle weakness from inherited gene mutations. Combined, they affect about 1 in 5,000 to 8,000 people. Common subtypes vary by age of onset ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results